FIELD: medicine, pharmacy. SUBSTANCE: agent has acetylsalicylic acid and ammonium succinate. EFFECT: enhanced anti-inflammatory effectiveness, decreased toxicity. 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS BASED ON NONSTEROID ANTI-INFLAMMATORY AGENTS | 2000 |
|
RU2191582C2 |
| ANTIINFLAMMATORY AGENT | 1994 |
|
RU2118161C1 |
| METHOD OF INCREASE OF ACTIVITY OF COMPOSITIONS BASED ON COMPOUNDS OF PHENOLIC STRUCTURE | 1998 |
|
RU2143269C1 |
| CARDIOPROTECTIVE, ANTIARRHYTHMIC ANTI-ISHEMIC AGENT | 2007 |
|
RU2366426C2 |
| NATURAL PHOSPHOLIPID AGENT | 2008 |
|
RU2367443C1 |
| ANTIHYPERLIPIDEMIC AGENT (VARIANTS) | 2002 |
|
RU2228746C1 |
| DRUG ACTING ON METABOLIC PROCESSES | 1996 |
|
RU2114618C1 |
| AGENT ACTIVATING METABOLIC PROCESSES | 1997 |
|
RU2143265C1 |
| PHARMACEUTICAL COMPOSITION BASED ON INDOMETHACIN MENTHYL ESTER IN FORM OF SOLID SELF-EMULSIFYING SYSTEM | 2023 |
|
RU2823982C1 |
| PHARMACEUTICAL COMPOSITIONS BASED ON INDOMETHACIN MENTHYL ETHER AND THEIR APPLICATION AS ANTI-INFLAMMATORY AGENTS | 2017 |
|
RU2685257C1 |
Authors
Dates
1999-08-27—Published
1997-03-11—Filed